ADMA induces monocyte adhesion via activation of chemokine receptors in cultured THP-1 cells

Cytokine

Volumn 43, Issue 2, 2008, Pages 149-159

  Chen, Meifang ^a,b   Li, Yuanjian ^b   Yang, Tianlun ^a   Wang, Yongjin ^c   Bai, Yongping ^a   Xie, Xiumei ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CHANGZHI MEDICAL COLLEGE   (China)

Author keywords

Angiotensin II (Ang II); Asymmetric dimethylarginine (ADMA); Chemokine; Dimethylarginine dimethylaminohydrolase (DDAH); Protein arginine methyltransferase (PRMT)

Indexed keywords

ANGIOTENSIN II; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; DIMETHYLARGININASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LOSARTAN; MEMBRANE PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G),N(G) DIMETHYLARGININE; PROTEIN ARGININE METHYLTRANSFERASE; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; UMBILICAL VEIN;

AMIDOHYDROLASES; ANGIOTENSIN II; ARGININE; CELL ADHESION; CELLS, CULTURED; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; MONOCYTES; PROTEIN-ARGININE N-METHYLTRANSFERASE; REACTIVE OXYGEN SPECIES; RECEPTORS, CHEMOKINE; RNA, MESSENGER; STEREOISOMERISM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 48049107754     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.05.001     Document Type: Article

References (33)

1. 2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function. J Lipid Res 40 (1999) 1053-1063
2. Dol F., Martin G., Staels B., Mares A.M., Cazaubon C., Nisato D., et al. Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 38 (2001) 395-405
3. 2 in atherosclerosis. Immunol Res 21 (2000) 129-137
4. Nabah Y.N., Mateo T., Estellés R., Mata M., Zagorski J., Sarau H., et al. Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines. Circulation 110 (2004) 3581-3586
5. Hayashi T., Juliet P.A., Miyazaki A., Ignarro L.J., and Iguchi A. High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis. Biochim Biophys Acta 1772 (2007) 364-372
6. Boger R.H. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59 (2003) 824-833
7. Sydow K., Schwedhelm E., Arakawa N., Bode-Böger S.M., Tsikas D., Hornig B., et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins. Cardiovasc Res 57 (2003) 244-252
8. Jiang D.J., Jia S.J., Dai Z., and Li Y.J. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in endothelial cells. J Mol Cell Cardiol 40 (2006) 529-539
9. Yuan Q., Jiang D.J., Chen Q.Q., Wang S., Xin H.Y., Deng H.W., et al. Role of asymmetric dimethylarginine in homocysteine-induced apoptosis of vascular smooth muscle cells. Biochem Biophys Res Commun 356 (2007) 880-885
10. Smirnova I.V., Kajstura M., Sawamura T., and Goligorsky M.S. Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation. Am J Physiol Heart Circ Physiol 287 (2004) H782-H790
11. Schmeisser A., Soehnlein O., Illmer T., Lorenz H.M., Eskafi S., Roerick O., et al. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-κB activity and AT1 receptor expression. Biochem Biophys Res Commun 325 (2004) 532-540
12. Soehnlein O., Schmeisser A., Cicha I., Reiss C., Ulbrich H., Lindbom L., et al. ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression. J Vasc Res 42 (2005) 399-407
13. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., and Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 (1999) 3092-3095
14. Osanai T., Saitoh M., Sasaki S., Tomita H., Matsunaga T., and Okumura K. Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 42 (2003) 985-990
15. Tain Y.L., Freshour G., Dikalova A., Griendling K.K., and Baylis C. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am J Physiol Renal Physiol 292 (2007) F1404-F1410
16. Jacobi J., Sydow K., von Degenfeld G., Zhang Y., Dayoub H., Wang B., et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation 111 (2005) 1431-1438
17. Caroline L.S., Graeme M.B., Shelagh A., Francesca I.A., James M.L., and Patrick V. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype. Biochem Biophys Res Commun 308 (2003) 984-989
18. Chen M.F., Xie X.M., Yang T.L., Wang Y.J., Zhang X.H., Luo B.L., et al. Involvement of asymmetric dimethylarginine in inflammatory reaction by angiotensin II. J Vasc Res 44 (2007) 391-402
19. Napoli C., Sica V., de Nigris F., Pignalosa O., Condorelli M., Ignarro L.J., et al. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 148 (2004) e5
20. Chen J.W., Hsu N.W., Wu T.C., Lin S.J., and Chang M.S. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 90 (2002) 974-982
21. Yilmaz M.I., Saglam M., Sonmez A., Caglar K., Cakir E., Kurt Y., et al. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril versus valsartan. Blood Purif 25 (2007) 327-335
22. 2 increase with age and alter vascular smooth muscle cell function. Arterioscler Thromb Vasc Biol 24 (2004) 1397-1402
23. Bush E., Maeda N., Kuziel W.A., Dawson T.C., Wilcox J.N., DeLeon H., et al. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 36 (2000) 360-363
24. Guo J., Van Eck M., de Waard V., Maeda N., Benson G.M., Groot P.H., et al. The presence of leukocyte CC-chemokine receptor 2 in CCR2 knockout mice promotes atherogenesis. Biochim Biophys Acta 1740 (2005) 453-459
25. Ishibashi M., Egashira K., Zhao Q., Hiasa K., Ohtani K., Ihara Y., et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 24 (2004) e174-e178
26. Abe Y., Fornage M., Yang C.Y., Bui-Thanh N.A., Wise V., Chen H.H., et al. L5, the most electronegative subfraction of plasma LDL, induces endothelial vascular cell adhesion molecule 1 and CXC chemokines, which mediate mononuclear leukocyte adhesion. Atherosclerosis 192 (2007) 56-66
27. 2 expression in monocytes via scavenger receptors and activation of p38 mitogen-activated protein kinase. Cardiovasc Res 53 (2003) 524-532
28. Boger R.H., Bode-Boger S.M., Tsao P.S., Lin P.S., Chan J.R., and Cooke J.P. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 36 (2000) 2287-2295
29. Leiper J., Murray-Rust J., McDonald N., and Vallance P. S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc Natl Acad Sci USA 99 (2002) 13527-13532
30. Chen X.L., Tummala P.E., Olbrych M.T., Alexander R.W., and Medford R.M. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83 (1998) 952-959
31. Saran R., Novak J.E., Desai A., Abdulhayoglu E., Warren J.S., Bustami R., et al. Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. Nephrol Dial Transplant 18 (2003) 2415-2420
32. Wells S.M., and Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative Stress in murine lung epithelial cells. Am J Respir Cell Mol Biol 36 (2007) 520-528
33. Kumar S.N., and Boss J.M. Site A of the MCP-1distal regulatory region function as a transcriptional modulator through the transcription factor NF1. Mol Immunol 37 (2000) 623-632